Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramaswamy Govindan

Showing results (1-10 of 358) with videos related to

Pageof 36
Sort By:
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 4, 2010
[A review of epidermal growth factor receptor/HER2 inhibitors in the treatment of patients with non-small-cell lung cancer]Ramaswamy Govindan
The New England Journal of Medicine|April 30, 2015
Overcoming resistance to targeted therapy for lung cancerRamaswamy Govindan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: yes, for EGFR mutation analysis, others, I PASSRamaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 20, 2012
The articles in this supplement should be viewed more as meeting reports than as exhaustive and comprehensive review articles. IntroductionRamaswamy Govindan
Current Treatment Options in Oncology|January 15, 2003
Management of patients with non-small cell lung cancer and poor performance statusRamaswamy Govindan
The Lancet. Oncology|September 22, 2011
Hope without hype: EML4-ALK inhibition for treatment of lung cancerRamaswamy Govindan
Clinical Lung Cancer|January 21, 2010
A review of epidermal growth factor receptor/HER2 inhibitors in the treatment of patients with non-small-cell lung cancerRamaswamy Govindan
Nature Clinical Practice. Oncology|November 3, 2005
Chemotherapy for metastatic NSCLC: current status and future directionRamaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Summary of the proceedings from the 10th annual meeting of molecularly targeted therapy in non-small cell lung cancerRamaswamy Govindan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Cetuximab in advanced non-small cell lung cancerRamaswamy Govindan
Pageof 36

Showing results (1-10 of 358) with videos related to

Sort By:
Pageof 36
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 4, 2010
[A review of epidermal growth factor receptor/HER2 inhibitors in the treatment of patients with non-small-cell lung cancer]Ramaswamy Govindan
The New England Journal of Medicine|April 30, 2015
Overcoming resistance to targeted therapy for lung cancerRamaswamy Govindan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: yes, for EGFR mutation analysis, others, I PASSRamaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 20, 2012
The articles in this supplement should be viewed more as meeting reports than as exhaustive and comprehensive review articles. IntroductionRamaswamy Govindan
Current Treatment Options in Oncology|January 15, 2003
Management of patients with non-small cell lung cancer and poor performance statusRamaswamy Govindan
The Lancet. Oncology|September 22, 2011
Hope without hype: EML4-ALK inhibition for treatment of lung cancerRamaswamy Govindan
Clinical Lung Cancer|January 21, 2010
A review of epidermal growth factor receptor/HER2 inhibitors in the treatment of patients with non-small-cell lung cancerRamaswamy Govindan
Nature Clinical Practice. Oncology|November 3, 2005
Chemotherapy for metastatic NSCLC: current status and future directionRamaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Summary of the proceedings from the 10th annual meeting of molecularly targeted therapy in non-small cell lung cancerRamaswamy Govindan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Cetuximab in advanced non-small cell lung cancerRamaswamy Govindan
Pageof 36